• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24133 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2004     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Percutaneous vertebroplasty. Pain management of osteoporotic vertebral fractures
2007     New Zealand Health Technology Assessment (NZHTA) Performance of commercially available HPV tests
2008     NIHR Health Technology Assessment programme Performance of screening tests for child physical abuse in accident and emergency departments
2012     Belgian Health Care Knowledge Centre (KCE) Performance of the Belgian Health System. Report 2012
2004     Adelaide Health Technology Assessment (AHTA) Perfusion CT scanning to evaluate cerebral perfusion in patients presenting with acute ischaemic stroke symptoms.
2007     Penn Medicine Center for Evidence-based Practice (CEP) Peri-operative blood conservation in adults - an evidence-based protocol
1994     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Peri-surgical nutritional support (TPN or EN) in adults - consensus conference
2023     Austrian Institute for Health Technology Assessment (AIHTA) Perinatal and infant mental health care in Austria. A mapping of existing prevention, screening and care structures, with a specific focus on Tyrol
2022     Austrian Institute for Health Technology Assessment (AIHTA) Perinatal and infant mental health care models and pathways
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Perinatal Care at the threshold of viability Part II: Decision-making at the threshold of viability and ethical challenges at Neonatal Intensive Care Units (NICUs)
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Perinatal care at the threshold of viability; Part I: Systematic analysis of outcomes and resource needs for neonatal intensive care units to inform healthcare planning
2005     Agency for Healthcare Research and Quality (AHRQ) Perinatal depression: prevalence, screening accuracy, and screening outcomes
2007     Adelaide Health Technology Assessment (AHTA) Perinatal Hepatitis C screening
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Periodic dental examinations for oral health: a review of clinical effectiveness, cost effectiveness, and guidelines
2013     Health Quality Ontario (HQO) Periodic health examinations: a rapid economic analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Periodontal regenerative procedures for patients with periodontal disease: a review of clinical effectiveness
2006     Haute Autorite de sante (HAS) Perioperative blood salvage
2005     NIHR Horizon Scanning Centre (NIHR HSC) Perioperative chemotherapy for operable gastro-oesophageal cancer - horizon scanning review
2022     NIHR Health Services and Delivery Research programme Perioperative exercise programmes to promote physical activity in the medium to long term: systematic review and qualitative research
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Periostat for periodontal disease: a review of the clinical effectiveness, cost effectiveness and guidelines
2022     Penn Medicine Center for Evidence-based Practice (CEP) Peripartum or postnatal care disparities and equity
1997     University HealthSystem Consortium (UHC) Peripheral blood progenitor cell transplantation
2017     HAYES, Inc. Peripheral nerve ablation for treatment of osteoarthritic knee pain
2014     Health Quality Ontario (HQO) Peripheral nerve blocks for post-operative pain relief after arthroscopic knee ligament reconstruction: a rapid review
2006     HAYES, Inc. Peripheral nerve decompression for diabetic neuropathy
2024     Ontario Health Peripheral nerve stimulation for chronic neuropathic pain
2024     Ontario Health Peripheral nerve stimulation for chronic neuropathic pain: a health technology assessment
2013     National Institute for Health and Care Excellence (NICE) Peripheral nerve-field stimulation for chronic low back pain. NICE interventional procedures guidance 451
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Peripherally inserted central catheter-associated mast cell activation syndrome: clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Peripherally Inserted Central Catheters (PICCs) for adult and pediatric patients: a review of clinical evidence
2016     HAYES, Inc. Peristeen anal irrigation system (Coloplast) for bowel management in pediatric populations
2018     National Institute for Health and Care Excellence (NICE) Peristeen Plus transanal irrigation system for managing bowel dysfunction. NICE medical technologies guidance 36
2006     Medical Services Advisory Committee (MSAC) Peritonectomy (nationally funded centres)
2012     National Institute for Health and Care Excellence (NICE) PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites. NICE medical technologies guidance 9
2010     Penn Medicine Center for Evidence-based Practice (CEP) Permacol implants for hernia repair
2021     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Permanent acute coronary syndrome event detector (insertion, removal or replacement of) for monitoring of the heart's electrical activity
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Permanent and semi permanent dermal fillers
2021     National Institute for Health and Care Excellence (NICE) Permanent His-bundle pacemaker implantation for treating heart failure. NICE interventional procedures guidance 694
2025     Health Technology Wales (HTW) Permanent implant brachytherapy devices for the treatment of locally advanced, unresectable pancreatic cancer
1999     ECRI Permanent prostate brachytherapy for localized prostate cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Permaseal for soft tissue access and closure during procedures
2015     HAYES, Inc. Peroral Endoscopic Myotomy (POEM) for treatment of esophageal achalasia
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Personal protective equipment and evidence-based advice for surgical departments during COVID-19
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protective equipment for antibiotic resistant organisms in rehabilitation facilities: clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Personal wireless device use for wound care consultation: a review of safety, clinical benefits and guidelines
2022     National Institute for Health and Care Excellence (NICE) Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome. NICE interventional procedures guidance 724
2019     Health Quality Ontario (HQO) Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis
2012     Health Council of the Netherlands Gezondheidsraad (GR) Perspectives on oral health care
1997     Health Council of the Netherlands Gezondheidsraad (GR) Pertussis: a critical appraisal
2000     Health Council of the Netherlands Gezondheidsraad (GR) Pertussis: a critical appraisal (2)
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pertuzumab (Omnitarg/Perjeta®) for the first-line therapy of metastatic HER2 positive breast cancer
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pertuzumab (Perjeta) for HER2-positive locally advanced, inflammatory or early breast cancer – neo-adjuvant in combination with trastuzumab and docetaxel
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pertuzumab (Perjeta) with chemotherapy and trastuzumab for HER2-positive early breast cancer – adjuvant therapy
2019     National Institute for Health and Care Excellence (NICE) Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer. NICE technology appraisal guidance 569
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pertuzumab for metastatic HER2-positive gastric cancer – first line
2016     National Institute for Health and Care Excellence (NICE) Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer. NICE technology appraisal guidance 424
2013     NIHR Health Technology Assessment programme Pertuzumab in combination with trastuzumab and docetaxel for the treatment of HER2 positive metastatic or locally recurrent unresectable breast cancer: a single technology appraisal
2018     National Institute for Health and Care Excellence (NICE) Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer. NICE technology appraisal guidance 509
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pesky gNATs cognitive behaviour therapy for children with anxiety and low mood
2002     ECRI PET for diagnosis of Alzheimer's disease
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) PET in non-neurological clinical oncology. IPE-97/11 (Public report)
2001     Institute for Clinical Systems Improvement (ICSI) PET scans for solitary pulmonary nodules, non-small cell lung cancer, recurrent colorectal cancer, lymphoma, and recurrent melanoma
2019     Andalusian Health Technology Assessment Area (AETSA) PET usefulness in non-oncological indications
2004     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) PET-CT: indications, systematic review and meta-analysis IPE-04/41 (Public report)
2017     NIHR Health Technology Assessment programme PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer
2017     NIHR Health Technology Assessment programme PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer
2018     NIHR Health Technology Assessment programme PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
2025     Institute of Health Economics (IHE) PET/CT capacity for cancer diagnosis and follow-up: rapid review
2013     Scottish Health Technologies Group (SHTG) PET/CT for the inversitgation of paraneoplastic syndromes (PNS)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) PET/PET-CT Evidence for need based planning in Germany and Austria
2010     HAYES, Inc. Peutz-Jeghers Syndrome (PJS)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pexiganan (Locilex) for mild foot infection in diabetic foot ulcers
2008     HAYES, Inc. PGxPredic: Rituximab Test (PGxHealth) for FCGR3A variants in follicular CD20-positive non-Hodgkin's Lymphoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) Phagenyx™ for stroke-induced dysphagia
2002     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Phakic intraocular lens implantation - systematic review, expert panel
2009     Medical Advisory Secretariat (MAS) Phakic intraocular lenses for the treatment of low to high refractive errors: an evidence-based analysis
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Phallometric assessment of sex offenders: a review of the clinical evidence and guidelines
1996     Alberta Heritage Foundation for Medical Research (AHFMR) Phalloplasty in female-male transsexuals
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pharma: Disclosure of transfers of value in Austria 2018. Update of the systematic analysis 2015
2009     Belgian Health Care Knowledge Centre (KCE) Pharmaceutical and non-pharmaceutical interventions for Alzheimer's Disease, a rapid assessment
2009     Belgian Health Care Knowledge Centre (KCE) Pharmaceutical and nonpharmaceutical interventions for Alzheimer’s disease, a rapid assessment
2018     Adelaide Health Technology Assessment (AHTA) Pharmaceutical Benefits Scheme post-market review of Pulmonary Arterial Hypertension medicines
1996     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Pharmaceutical management of gastroesophageal reflux disease - summary
1996     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Pharmaceutical management of peptic ulcer disease
2000     Israel Center for Technology Assessment in Health Care (ICTAHC) Pharmaceutical services in Israeli hospitals - a national survey
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Pharmacoeconomic evaluation in schizophrenia: clozapine in treatment-resistant schizophrenia and risperidone in chronic schizophrenia
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Pharmacoeconomic evaluations of clozapine in treatment-resistant schizophrenia and risperidone in chronic schizophrenia - summary
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Ingenol mebutate (Picato LEO Pharma Inc.) indication: topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Lurasidone (Latuda - Sunovion Pharmaceuticals Inc.) indication: schizophrenia
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Ocriplasmin (Jetrea - Alcon Canada Inc.) indication: symptomatic vitreomacular adhesion
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Saxagliptin (Onglyza - Bristol-Myers Squibb/AstraZeneca Canada Inc.) indication: type 2 diabetes mellitus
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Sofosbuvir (Sovaldi — Gilead Sciences Canada, Inc.) indication: chronic hepatitis C infection
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Teriflunomide (Aubagio — Genzyme Canada) indication: relapsing-remitting multiple sclerosis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Ulipristal Acetate (Fibristal - Actavis Specialty Pharmaceuticals Co.) indication: uterine fibroids
2019     Health Technology Wales (HTW) Pharmacogenetic testing to identify the risk of adverse reactions to anti-epileptic medications